Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Appili Therapeutics Inc Class A (TSE:APLI)
TSX:APLI
Holding TSE:APLI?
Track your performance easily
APLI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.06
Previous CloseN/A
Volume36.33K
Average Volume (3M)41.70K
Market Cap
$3.64M
Enterprise ValueC$13.39M
Total Cash (Recent Filing)$5.75M
Total Debt (Recent Filing)$1.09M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Feb 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding121,266,120
10 Day Avg. Volume63,819
30 Day Avg. Volume41,698
Standard Deviation0.29
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.40
Price to Cash Flow (P/CF)-6.90
P/FCF Ratio0.80
Enterprise Value/Market Cap3.68
Enterprise Value/Revenue16.19
Enterprise Value/Gross Profit16.19
Enterprise Value/Ebitda-10.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Appili Therapeutics Inc Class A News
PremiumCompany Announcements
Appili Therapeutics Moves Forward with Aditxt Acquisition
PremiumCompany Announcements
Appili Therapeutics Highlights Progress and Shareholder Support
PremiumCompany Announcements
Appili Shareholders Approve Acquisition by Aditxt
PremiumCompany Announcements
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
APLI FAQ
What was Appili Therapeutics Inc Class A’s price range in the past 12 months?
Appili Therapeutics Inc Class A lowest stock price was C$0.03 and its highest was C$0.06 in the past 12 months.
What is Appili Therapeutics Inc Class A’s market cap?
Appili Therapeutics Inc Class A’s market cap is $3.64M.
When is Appili Therapeutics Inc Class A’s upcoming earnings report date?
Appili Therapeutics Inc Class A’s upcoming earnings report date is Feb 18, 2025 which is in 19 days.
How were Appili Therapeutics Inc Class A’s earnings last quarter?
Appili Therapeutics Inc Class A released its earnings results on Nov 14, 2024. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Appili Therapeutics Inc Class A overvalued?
According to Wall Street analysts Appili Therapeutics Inc Class A’s price is currently Overvalued.
Does Appili Therapeutics Inc Class A pay dividends?
Appili Therapeutics Inc Class A does not currently pay dividends.
What is Appili Therapeutics Inc Class A’s EPS estimate?
Appili Therapeutics Inc Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Appili Therapeutics Inc Class A have?
Appili Therapeutics Inc Class A has 121,266,120 shares outstanding.
What happened to Appili Therapeutics Inc Class A’s price movement after its last earnings report?
Appili Therapeutics Inc Class A reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.286%.
Which hedge fund is a major shareholder of Appili Therapeutics Inc Class A?
Currently, no hedge funds are holding shares in TSE:APLI
---
Company Description
Appili Therapeutics Inc Class A
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
---
Technical Analysis
Microbix Biosystms
―
Resverlogix
―
Thor Explorations
―
DIRTT Environmental Solutions
―
---